Publications by authors named "Tim Postmus"

Claim this Profile
T
Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.
Tim Postmus, Robin Jansen, Paul Kaijen, Floris van Alphen, Carmen van der Zwaan

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP.
Tim Postmus, Nelly Schilder, Juliana Ferreira de Santana, Pieter Langerhorst, Paul Kaijen

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura.
Tim Postmus, Nuno A G Graça, Juliana Ferreira de Santana, Bogac Ercig, Pieter Langerhorst

J Thromb Haemost· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation FVIII mimetic bispecific antibody for hemophilia A.
Jan Voorberg, Tim Postmus, Saskia Schols

J Thromb Haemost· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis